Sarna spent the past year as a visiting partner ... which looked to manufacture devices that could detect the deadly disease in a woman’s fallopian tubes. “It took me a year and 50-plus ...

Y Combinator's Surbhi Sarna has raised $30 million for Collate ... the cause of the mysterious disease in Congo, new rules on pulse oximeters and more.

Vaccines are critical to disease prevention and infection control ... types of challenges by researching self-amplifying RNA (saRNA) and novel antigen-design technologies. saRNA is a novel vaccine ...

Harnessing the targeted gene manipulation in cells enabled by ChaESAR, Chimeron is developing a compelling portfolio of innovative saRNA-based vaccines and therapeutics for infectious diseases ...

By leveraging this modified saRNA platform, Keylicon aims to develop new vaccines and therapeutics to address indications in infectious disease and cancer. Through a combination of academic ...